Dementia & Cognitive Decline Protocol

NeurologicalEmerging Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Omega-3 DHAB

1000-2000mg DHA daily

Primary structural fatty acid in brain; supports neuronal membrane integrity and reduces neuroinflammation

20 studies3,500 participants

Supporting Studies (1)

PMID: 29350588 - Omega-3 and cognitive decline meta-analysis (2018)

PhosphatidylserineB

300mg daily

Membrane phospholipid that supports neurotransmitter function and neuronal signaling

↓Cognitive Decline

10 studies600 participants

Supporting Studies (1)

PMID: 21103034 - Phosphatidylserine and cognitive function (2010)

Supporting Stack

Additional supplements for enhanced results

Lion's Mane MushroomB

1000-3000mg daily

Contains hericenones and erinacines that stimulate nerve growth factor (NGF) synthesis

5 studies180 participants

Supporting Studies (1)

PMID: 18844328 - Lion's mane improves cognitive function in mild cognitive impairment (2009)

Citicoline (CDP-Choline)B

500-1000mg daily

Provides choline for acetylcholine synthesis and supports phosphatidylcholine production

12 studies850 participants

Bacopa MonnieriB

300-450mg daily (standardized to 50% bacosides)

Adaptogenic herb that enhances synaptic communication and has antioxidant effects

9 studies520 participants

Vitamin E (mixed tocopherols)B

400-800 IU daily

Antioxidant that protects brain lipids from oxidation; may slow functional decline

Alzheimer's Disease Risk↑Cognition

8 studies1,200 participants

How This Protocol Works

Simple Explanation

Dementia involves progressive loss of brain cells and connections due to factors like oxidative stress, inflammation, and reduced blood flow. While no supplement can cure dementia, several may support brain health and potentially slow decline.

•DHA (omega-3) makes up 40% of brain fatty acids. Studies show people with higher DHA levels have slower cognitive decline. It reduces neuroinflammation and supports synaptic function.

•Phosphatidylserine is a key component of brain cell membranes. It supports neurotransmitter systems and cell-to-cell communication. Multiple studies show modest cognitive benefits.

•Lion's mane mushroom contains compounds that stimulate nerve growth factor (NGF), which supports neuron survival and growth. A Japanese study showed significant cognitive improvement in mild cognitive impairment.

•Citicoline provides building blocks for both acetylcholine (memory neurotransmitter) and brain cell membranes. It has decades of research in cognitive support.

•Bacopa is an Ayurvedic herb that enhances memory and learning, likely through antioxidant effects and enhanced nerve signaling.

•Vitamin E protects brain fats from oxidation. The TEAM-AD study showed it slowed functional decline in mild-moderate Alzheimer's.

Important: Supplements cannot reverse established dementia. Work with a neurologist for comprehensive care.

Expected timeline: Cognitive supplements typically require 3-6 months for noticeable effects.

Clinical Perspective

Dementia pathophysiology includes amyloid-β accumulation, tau hyperphosphorylation, oxidative stress, neuroinflammation, cholinergic deficits, and synaptic loss. This protocol targets modifiable factors.

•DHA (B-grade): Comprises 40% of brain polyunsaturated fatty acids. Maintains membrane fluidity, supports BDNF expression, reduces microglial activation. Meta-analysis (PMID: 29350588): beneficial for MCI, less clear for established dementia. Best evidence is for prevention.

•Phosphatidylserine (B-grade): Aminophospholipid in neuronal membranes. Modulates PKC, Na+/K+-ATPase, and neurotransmitter release. Meta-analysis (PMID: 21103034): consistent improvements in memory and attention in age-related cognitive decline.

•Lion's mane (B-grade): Hericenones cross BBB and stimulate NGF synthesis via CREB pathway. RCT (PMID: 18844328): 3g/day × 16 weeks significantly improved cognitive function in MCI (HDS-R scale); benefits reversed after discontinuation.

•Citicoline (B-grade): Precursor for phosphatidylcholine synthesis; increases acetylcholine. Improves cerebral metabolism and blood flow. Cochrane review showed modest benefits in dementia with vascular component.

•Bacopa monnieri (B-grade): Bacosides modulate serotonergic, dopaminergic, and cholinergic systems. Inhibits acetylcholinesterase. Meta-analysis showed improved attention and cognitive processing.

•Vitamin E (B-grade): TEAM-AD trial (PMID: 24381967): 2000 IU/day slowed functional decline in mild-moderate AD by 19% over 2 years. Concerns about high-dose mortality may not apply when functional benefit exists.

Prevention vs treatment: Strongest evidence is for prevention (omega-3, antioxidants). Established dementia benefits are more modest.

Monitoring: MMSE, MoCA, functional assessments. Consider amyloid PET or CSF biomarkers if available.

Note: Does not replace cholinesterase inhibitors or memantine when indicated.

View All Protocols